Featured 13F manager
Shah Capital Management Himanshu Shah
Raleigh, NC 22 processed 13Fs on this site · 2021 Q3–2026 Q2
- $526M
- 9 Positions
- 2026 Q2
- +1.0% QoQ
- Top 5 91.1%
Himanshu Shah files Shah Capital Management as a Form 13F. The latest book is 2026 Q2 at $526M, up 1.0% QoQ, led by Vimpelcom, Novavax, and China Yuchai Intl.
Portfolio
top 5 91.1% · top 10 100.0%
- VEON - Vimpelcom 46.3%
- NVAX - Novavax 25.4%
- CYD - China Yuchai Intl 12.1%
- VGSH - Vanguard Scottsdale Fds 4.2%
- TROX - Tronox 3.1%
- CSIQ - Canadian Solar 2.8%
- EDU — 2.6%
- AM - Antero Midstream 2.4%
- DOLE - DOLE PLC 1.1%
AUM over time
Book
| VEON - Vimpelcom | 44.09% | Reduce −0.5% | 4,918,757 | $46.07 | $227M | −24,033 | +$11M |
| CYD - China Yuchai Intl | 15.14% | Reduce −2.1% | 3,255,185 | $23.91 | $78M | −68,837 | +$21M |
| NVAX - Novavax | 14.11% | Add +3.4% | 11,511,780 | $6.30 | $73M | +379,934 | +$1M |
| Emeren Group | 6.85% | Hold | 18,818,236 | $1.87 | $35M | — | — |
| VGSH - Vanguard Scottsdale Fds | 4.28% | Hold | 373,988 | $58.78 | $22M | — | — |
| CSIQ - Canadian Solar | 4.04% | Reduce −1.3% | 1,880,885 | $11.04 | $21M | −25,400 | +$4M |
| EDU — | 3.20% | Reduce −0.3% | 305,317 | $53.95 | $16M | −933 | +$2M |
| AM - Antero Midstream | 2.16% | Reduce −23.5% | 586,000 | $18.95 | $11M | −179,565 | −$3M |
| PARA - Paramount Global · CLASS B | 1.98% | Reduce −41.0% | 790,173 | $12.90 | $10M | −550,000 | −$6M |
| GCI - Gannett | 1.25% | Hold | 1,800,000 | $3.58 | $6M | — | — |
| VAL - Valaris · CL A | 0.99% | Hold | 120,506 | $42.11 | $5M | — | — |
| DOLE - DOLE PLC | 0.74% | Hold | 271,232 | $13.99 | $4M | — | — |
| Cheer · CL A | 0.60% | Add +23.8% | 2,110,000 | $1.46 | $3M | +404,950 | +$813K |
| BIDU - Baidu | 0.57% | Add +143.5% | 33,935 | $85.76 | $3M | +20,000 | +$2M |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2025 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Genworth Finl | 1.58% | Exit | 0 | $7.09 | $8M | −1,090,743 | −$8M |
| Wolfspeed | 1.35% | Exit | 0 | $3.06 | $7M | −2,152,225 | −$7M |
| Xerox | 0.41% | Exit | 0 | $4.83 | $2M | −418,794 | −$2M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 9 | $526M | +1.0% | 13F-HR | 8/14/2026 | 000139834426014600 |
| 2026 Q1 | 11 | $521M | +0.4% | 13F-HR | 4/24/2026 | 000139834426007059 |
| 2025 Q4 | 12 | $519M | −7.2% | 13F-HR | 1/15/2026 | 000139834426000720 |
| 2025 Q3 | 13 | $559M | +8.8% | 13F-HR | 11/12/2025 | 000139834425020706 |
| 2025 Q2 | 14 | $514M | +4.9% | 13F-HR | 7/23/2025 | 000139834425013573 |
| 2025 Q1 | 17 | $490M | −1.2% | 13F-HR | 5/14/2025 | 000139834425009346 |
| 2024 Q4 | 16 | $496M | −3.3% | 13F-HR | 1/22/2025 | 000139834425000895 |
| 2024 Q3 | 19 | $513M | +11.0% | 13F-HR | 10/15/2024 | 000139834424018895 |
| 2024 Q2 | 17 | $462M | +29.4% | 13F-HR | 8/12/2024 | 000139834424014293 |
| 2024 Q1 | 17 | $357M | −8.5% | 13F-HR | 5/15/2024 | 000139834424009614 |
| 2023 Q4 | 15 | $390M | −7.8% | 13F-HR | 2/5/2024 | 000139834424002083 |
| 2023 Q3 | 14 | $423M | +8.7% | 13F-HR | 10/11/2023 | 000138383823000016 |
| 2023 Q2 | 15 | $394M | — | new holds | 7/13/2023 | 000138383823000009 |
| 2023 Q2 | 14 | $389M | +13.1% | 13F-HR | 7/12/2023 | 000138383823000007 |
| 2023 Q2 | 16 | $344M | — | new holds | 7/12/2023 | 000138383823000008 |
| 2023 Q1 | 16 | $344M | −18.3% | 13F-HR | 5/8/2023 | 000138383823000003 |
| 2022 Q4 | 15 | $421M | +20.3% | 13F-HR | 1/13/2023 | 000138383823000002 |
| 2022 Q3 | 12 | $350M | −9.3% | 13F-HR | 10/27/2022 | 000138383822000010 |
| 2022 Q2 | 13 | $386M | −0.3% | 13F-HR | 7/25/2022 | 000138383822000009 |
| 2022 Q1 | 12 | $387M | +3.2% | 13F-HR | 4/19/2022 | 000138383822000004 |
| 2021 Q4 | 10 | $375M | +1.4% | 13F-HR | 1/19/2022 | 000138383822000002 |
| 2021 Q3 | 9 | $370M | — | 13F-HR | 10/8/2021 | 000138383821000010 |
About
Shah Capital Management
22 processed 13Fs on this site · 2021 Q3–2026 Q2